Clearance Summary
VENTANA ER PRIMARY ANTIBODY (CLONE 6F11) received FDA 510(k) clearance under submission number K984567, sponsored by Ventana, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1999-08-12.
- Submission: K984567
- Applicant / Sponsor: Ventana, Inc.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.1860
- Decision date: 1999-08-12
Classification & Regulation
This clearance is catalogued under FDA product code MYA and 21 CFR 864.1860, within the Hematology review panel as a Class II device.